Gefitinib
Links shared publicly online about this topic
Gefitinib May Have Chemopreventive Benefits In Pancreatic Cancer
medicalnewstoday.com — “Gefitinib may be a promising chemoprevention agent for pancreatic cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Rese” View full resource at medicalnewstoday.com
Most Recently Shared on November 9, 2010 at 2:05 pm By:
MNT Pancreatic Can Health News
Gefitinib May Have Chemopreventive Benefits In Pancreatic Cancer http://mnt.to/3Mfq #pancreaticcancer
Gefitinib may have chemopreventive benefits in pancreatic cancer
physorg.com — “Gefitinib may be a promising chemoprevention agent for pancreatic cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.” View full resource at physorg.com
Most Recently Shared on November 8, 2010 at 8:33 pm By:
Gefitinib may have chemopreventive benefits in pancreatic cancer http://bit.ly/9oHRz8
Erlotinib or Gefitinib for Lung Cancer | Now@NEJM
blogs.nejm.org — “The latest article in our Clinical Therapeutics series, Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib, comes from Dr. Vince Cataldo at the” View full resource at blogs.nejm.org
Most Recently Shared on March 11, 2011 at 6:01 pm By:
NEJM: Erlotinib or Gefitinib for Lung Cancer http://bit.ly/ek58rA
Erlotinib or Gefitinib for Lung Cancer | Now@NEJM
blogs.nejm.org — “The latest article in our Clinical Therapeutics series, Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib, comes from Dr. Vince Cataldo at the” View full resource at blogs.nejm.org
Most Recently Shared on March 13, 2011 at 3:05 pm By:
Robert S. Miller, MD Oncologist, Physician, Doctor, and Internist
NEJM: Erlotinib or Gefitinib for Lung Cancer http://t.co/OT3Jwuj-->clinical pearls
Symposier - Dr. West on the Gefitinib Advanced NSCLC Trial
symposier.com — “Uploaded and shared in Youtube by: OncLiveTV — H. Jack West, MD, medical director of the Thoracic Oncology Program at the Swedish Cancer Institute in Seattle, Washington, discusses findings from a phase III, randomized, multicenter, parallel group study (NCT00770588) that examined the efficacy of gefitinib as a maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC). The trial discovered that progression free survival was much longer in Chinese patients receiving gefitin” View full resource at symposier.com
Most Recently Shared on July 25, 2011 at 10:21 pm By:
Dr. West on the Gefitinib Advanced non-small cell lung cancer Trial http://bit.ly/phCgdO
Second Round Of Gefitinib May Be Promising Lung Cancer Therapy
medicalnewstoday.com — “Patients with non-small cell lung cancer in whom treatment with gefitinib is ineffective often have limited options, but results of a new study suggest that retreating patients with the same drug ” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2010 at 6:37 pm By:
Second Round Of Gefitinib May Be Promising Lung Cancer Therapy Patients with non-small cell lung cancer in whom treat.. http://bit.ly/7E9vn1
IngentaConnect Gefitinib: Acute interstitial pneumonia: 2 case reports
ingentaconnect.com — “IngentaConnect Gefitinib: Acute interstitial pneumonia: 2 case reports” View full resource at ingentaconnect.com
Most Recently Shared on September 3, 2010 at 11:49 am By:
Gefitinib: Acute interstitial pneumonia: 2 case reports: (Source: Reactions)MedWorm Message: Register for MedMatch... http://bit.ly/arTYof
Second round of gefitinib may be promising lung cancer therapy
physorg.com — “Patients with non-small cell lung cancer in whom treatment with gefitinib is ineffective often have limited options, but results of a new study suggest that retreating patients with the same drug could have a beneficial effect.” View full resource at physorg.com
Most Recently Shared on January 13, 2010 at 10:59 am By:
Second round of gefitinib may be promising lung cancer therapy http://bit.ly/6Qpki4
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma - OncologySTAT
oncologystat.com — “N Engl J Med. 2009 Aug 19;361(8):1-11 - Asian study shows gefitinib is superior to carboplatin–paclitaxel as initial therapy for adenocarcinoma, especially if EGFR mutation is present.” View full resource at oncologystat.com
Most Recently Shared on August 26, 2009 at 8:12 pm By:
OncologySTAT Health Site and Oncology
Top Story of the Week: Gefitinib Improves PFS in Asian Patients With EGFR-Positive NSCLC http://tinyurl.com/ng562n
Oncology News - A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer |3985513
mdlinx.com — “Oncology Medical Article: A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer” View full resource at mdlinx.com
Most Recently Shared on March 23, 2012 at 5:09 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefit... http://t.co/jdwD5w6i #oncology
Gefitinib Receives European Licence For The Treatment Of Lung Cancer For Patients With EGFR Activating Mutation Positive Tumours
medicalnewstoday.com — “AstraZeneca announced that it has received a licence by the European Medicines Agency (EMEA) for its oral targeted anti-cancer drug, gefitinib, for EGFR (epidermal growth factor receptor-tyrosine” View full resource at medicalnewstoday.com
Most Recently Shared on July 4, 2009 at 3:59 pm By:
H. Jack West, MD Internist, Health Executive, Oncologist, Physician, and Doctor
Oral EGFR inhibitor Iressa approved in Europe for lung Ca pts w/EGFR mut'n: http://bit.ly/MmxPy - to me, cost is only benefit vs. tarceva
A Phase I/II Trial Of Gefitinib Given Concurrently With Radiotherapy In Patients With Nonmetastatic Prostate Cancer
medicalnewstoday.com — “UroToday.com - Combining radical radiotherapy with targeted drugs: a new primary treatment for aggressive prostate cancer? Current treatment results for prostate cancer are at an excellent level.” View full resource at medicalnewstoday.com
Most Recently Shared on June 21, 2010 at 3:37 pm By:
OrganizedWisdom Pets OW Health
A Phase I/II Trial Of Gefitinib Given Concurrently With Radiotherapy In Patients With Nonmetastatic Prostate Cance... http://mnt.to/f/3F7P
Erlotinib And Gefitinib Effective For Certain Lung Cancers, May Improve Quality Of Life, Survival
medicalnewstoday.com — “LSU oncologist Vince D. Cataldo, MD, is the lead author of a review article reporting two chemotherapy drugs now indicated for second and third-line therapy in patients with advanced non-small-cel” View full resource at medicalnewstoday.com
Most Recently Shared on March 14, 2011 at 9:39 am By:
Erlotinib And Gefitinib Effective For Certain Lung Cancers, May Improve Quality Of Life, Survival: LSU oncologis... http://bit.ly/flMc7b
Gefitinib for Non-small Cell Lung Cancer: A meta Analysis | GUO | Chinese Journal of Lung Cancer
lungca.org — “Gefitinib for Non-small Cell Lung Cancer: A meta Analysis” View full resource at lungca.org
Most Recently Shared on April 16, 2011 at 4:43 am By:
Gefitinib for Non-small Cell Lung Cancer: A meta Analysis: Conclusion Gifitinib shows more superiority for non-s... http://bit.ly/ev5TiV
First-line gefitinib doubled PFS in NSCLC with mutated EGFR | HemOncToday
hemonctoday.com — “First-line gefitinib doubled PFS in NSCLC with mutated EGFR | HemOncToday” View full resource at hemonctoday.com
Most Recently Shared on June 24, 2010 at 4:30 pm By:
HemOnc Today Oncology and Health News
First-line gefitinib doubled PFS in NSCLC with mutated EGFR http://ht.ly/22MbO
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Pancreatic Can
The latest pancreatic cancer news published daily. Articles from research centers, universities and prestigious journals.
-
FightCancer
Cancer news feed, formerly part of a blog. RSS suggestions welcome.
-
Kidney Notes
Interesting medical news not just kidney-related generated automatically.
Advertisement
